Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
tetracycline + lidocaine
- Development stage
- Unknown
- Modality
- Small Molecules
- Administration
- Intrapleural, Topical
01
Overview
A combination of tetracycline, a bacteriostatic antibiotic that inhibits bacterial protein synthesis and matrix metalloproteinases, with lidocaine, an amide-type local anesthetic that blocks sodium ion channels. This combination is primarily used for pleurodesis procedures to treat pleural effusions and pneumothorax, and in topical applications for pain relief during dermatological procedures.
02
Targets
MMP12 (Macrophage Metalloelastase)Bacterial RibosomeNaV alpha (Voltage-gated sodium channel alpha subunit family)
Beyond the preview
Go deeper on tetracycline + lidocaine.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on tetracycline + lidocaine.